Stock ABOS ACUMEN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Acumen Pharmaceuticals, Inc.

Equities

ABOS

US00509G2093

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
3.4 USD +1.19% Intraday chart for Acumen Pharmaceuticals, Inc. +4.62% -11.46%
May. 08 Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study MT
May. 08 Acumen Pharmaceuticals, Inc. Announces First Patient Dosed in Altitude-Ad, A Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer?S Disease CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: BYD, Activision, Microsoft, Rio Tinto, Tesla...Global markets live: BYD, Activision, Microsoft, Rio Tinto, Tesla... July 17, 2023 at 11:49 am EDT
In wait-and-see mode before Tesla and NetflixIn wait-and-see mode before Tesla and Netflix July 17, 2023 at 09:43 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABOS Stock
  4. News Acumen Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW